INDOCO REMEDIES
|
INDOCO REMEDIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr |
Equity - Authorised | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
Equity - Issued | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr |
Equity Paid Up | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | ₹3.54 Cr | ₹0.66 Cr | - | - | - |
Total Reserves | ₹1,088 Cr | ₹1,009 Cr | ₹886 Cr | ₹751 Cr | ₹661 Cr |
Securities Premium | ₹65 Cr | ₹64 Cr | ₹64 Cr | ₹64 Cr | ₹64 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹765 Cr | ₹687 Cr | ₹564 Cr | ₹428 Cr | ₹339 Cr |
General Reserves | ₹258 Cr | ₹258 Cr | ₹258 Cr | ₹258 Cr | ₹258 Cr |
Other Reserves | ₹0.23 Cr | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹1,088 Cr | ₹1,009 Cr | ₹886 Cr | ₹751 Cr | ₹661 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹1,110 Cr | ₹1,028 Cr | ₹905 Cr | ₹769 Cr | ₹680 Cr |
Minority Interest | ₹0.60 Cr | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹352 Cr | ₹144 Cr | ₹96 Cr | ₹97 Cr | ₹97 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹305 Cr | ₹190 Cr | ₹129 Cr | ₹110 Cr | ₹92 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹47 Cr | ₹-47 Cr | ₹-34 Cr | ₹-13 Cr | ₹4.87 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹12 Cr | ₹6.14 Cr | ₹11 Cr | ₹-19 Cr | ₹-36 Cr |
Deferred Tax Assets | ₹27 Cr | ₹26 Cr | ₹30 Cr | ₹62 Cr | ₹78 Cr |
Deferred Tax Liability | ₹38 Cr | ₹32 Cr | ₹40 Cr | ₹42 Cr | ₹42 Cr |
Other Long Term Liabilities | ₹25 Cr | ₹22 Cr | ₹18 Cr | ₹14 Cr | ₹13 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹34 Cr | ₹89 Cr | ₹32 Cr | ₹66 Cr | ₹27 Cr |
Total Non-Current Liabilities | ₹422 Cr | ₹261 Cr | ₹157 Cr | ₹158 Cr | ₹101 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹154 Cr | ₹123 Cr | ₹133 Cr | ₹113 Cr | ₹166 Cr |
Sundry Creditors | ₹154 Cr | ₹123 Cr | ₹133 Cr | ₹113 Cr | ₹166 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹150 Cr | ₹132 Cr | ₹140 Cr | ₹129 Cr | ₹136 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹7.61 Cr | ₹13 Cr | ₹3.72 Cr | ₹3.05 Cr | ₹6.43 Cr |
Interest Accrued But Not Due | - | - | - | - | ₹1.10 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹142 Cr | ₹119 Cr | ₹136 Cr | ₹126 Cr | ₹128 Cr |
Short Term Borrowings | ₹261 Cr | ₹119 Cr | ₹104 Cr | ₹117 Cr | ₹106 Cr |
Secured ST Loans repayable on Demands | ₹57 Cr | ₹19 Cr | ₹36 Cr | ₹33 Cr | ₹37 Cr |
Working Capital Loans- Sec | ₹53 Cr | ₹18 Cr | ₹34 Cr | ₹32 Cr | ₹36 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹150 Cr | ₹82 Cr | ₹34 Cr | ₹53 Cr | ₹33 Cr |
Short Term Provisions | ₹82 Cr | ₹50 Cr | ₹142 Cr | ₹47 Cr | ₹52 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹33 Cr | - | ₹94 Cr | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹48 Cr | ₹50 Cr | ₹47 Cr | ₹47 Cr | ₹52 Cr |
Total Current Liabilities | ₹645 Cr | ₹425 Cr | ₹518 Cr | ₹407 Cr | ₹459 Cr |
Total Liabilities | ₹2,178 Cr | ₹1,714 Cr | ₹1,579 Cr | ₹1,334 Cr | ₹1,240 Cr |
ASSETS | |||||
Gross Block | ₹1,781 Cr | ₹1,423 Cr | ₹1,236 Cr | ₹1,178 Cr | ₹1,127 Cr |
Less: Accumulated Depreciation | ₹826 Cr | ₹745 Cr | ₹681 Cr | ₹608 Cr | ₹537 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹954 Cr | ₹678 Cr | ₹555 Cr | ₹570 Cr | ₹590 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹103 Cr | ₹55 Cr | ₹53 Cr | ₹25 Cr | ₹7.33 Cr |
Non Current Investments | ₹1.46 Cr | ₹1.46 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr |
Long Term Investment | ₹1.46 Cr | ₹1.46 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹1.46 Cr | ₹1.46 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr |
Long Term Loans & Advances | ₹102 Cr | ₹110 Cr | ₹34 Cr | ₹72 Cr | ₹34 Cr |
Other Non Current Assets | ₹7.04 Cr | ₹2.25 Cr | ₹2.13 Cr | ₹2.06 Cr | ₹1.68 Cr |
Total Non-Current Assets | ₹1,190 Cr | ₹906 Cr | ₹712 Cr | ₹712 Cr | ₹676 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹7.24 Cr | ₹1.00 Cr | - | - | - |
Quoted | ₹7.24 Cr | ₹1.00 Cr | - | - | - |
Unquoted | ₹4.63 Cr | ₹4.63 Cr | ₹4.63 Cr | ₹4.63 Cr | ₹4.63 Cr |
Inventories | ₹353 Cr | ₹326 Cr | ₹311 Cr | ₹238 Cr | ₹208 Cr |
Raw Materials | ₹180 Cr | ₹200 Cr | ₹186 Cr | ₹137 Cr | ₹119 Cr |
Work-in Progress | ₹84 Cr | ₹57 Cr | ₹43 Cr | ₹39 Cr | ₹26 Cr |
Finished Goods | ₹62 Cr | ₹34 Cr | ₹55 Cr | ₹44 Cr | ₹45 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | ₹11 Cr | ₹12 Cr | ₹4.90 Cr | ₹7.64 Cr | ₹7.53 Cr |
Other Inventory | ₹17 Cr | ₹21 Cr | ₹22 Cr | ₹10 Cr | ₹10 Cr |
Sundry Debtors | ₹406 Cr | ₹351 Cr | ₹297 Cr | ₹234 Cr | ₹210 Cr |
Debtors more than Six months | ₹61 Cr | ₹61 Cr | ₹52 Cr | ₹63 Cr | ₹65 Cr |
Debtors Others | ₹377 Cr | ₹322 Cr | ₹262 Cr | ₹174 Cr | ₹152 Cr |
Cash and Bank | ₹24 Cr | ₹13 Cr | ₹20 Cr | ₹14 Cr | ₹38 Cr |
Cash in hand | ₹0.13 Cr | ₹0.14 Cr | ₹0.11 Cr | ₹0.07 Cr | ₹0.11 Cr |
Balances at Bank | ₹24 Cr | ₹13 Cr | ₹20 Cr | ₹14 Cr | ₹38 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹42 Cr | ₹20 Cr | ₹35 Cr | ₹12 Cr | ₹9.11 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹20 Cr | ₹12 Cr | ₹9.54 Cr | ₹8.63 Cr | ₹5.37 Cr |
Other current_assets | ₹22 Cr | ₹8.62 Cr | ₹25 Cr | ₹3.27 Cr | ₹3.75 Cr |
Short Term Loans and Advances | ₹155 Cr | ₹97 Cr | ₹205 Cr | ₹125 Cr | ₹98 Cr |
Advances recoverable in cash or in kind | ₹27 Cr | ₹22 Cr | ₹13 Cr | ₹24 Cr | ₹12 Cr |
Advance income tax and TDS | ₹35 Cr | - | ₹93 Cr | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹93 Cr | ₹75 Cr | ₹98 Cr | ₹101 Cr | ₹85 Cr |
Total Current Assets | ₹988 Cr | ₹808 Cr | ₹867 Cr | ₹623 Cr | ₹563 Cr |
Net Current Assets (Including Current Investments) | ₹342 Cr | ₹384 Cr | ₹349 Cr | ₹216 Cr | ₹104 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹2,178 Cr | ₹1,714 Cr | ₹1,579 Cr | ₹1,334 Cr | ₹1,240 Cr |
Contingent Liabilities | ₹167 Cr | ₹83 Cr | ₹60 Cr | ₹56 Cr | ₹52 Cr |
Total Debt | ₹655 Cr | ₹315 Cr | ₹244 Cr | ₹259 Cr | ₹262 Cr |
Book Value | - | 111.51 | 98.17 | 83.45 | 73.75 |
Adjusted Book Value | 120.02 | 111.51 | 98.17 | 83.45 | 73.75 |
Compare Balance Sheet of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹3,065.7 Cr | -0.8% | 5.2% | -16.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | -0.8% |
5.2% |
-16.7% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses